Predicting the Risk of Venous Thromboembolism in Critically Ill Patients
1 other identifier
observational
7,600
0 countries
N/A
Brief Summary
Introduction: Venous thrombosis (VTE), including both deep vein thrombosis (DVT) and pulmonary embolism (PE) remains a frequent complication in patients admitted to the Intensive Care Unit (ICU). Multiple prediction models for estimating the risk of VTE have been developed. However, many models have not been externally validated. The aim of this study is to perform a comprehensive external validation of pre-existing prediction models for predicting the risk of in-hospital VTE in critically ill patients. In case current risk assessment models fail, the investigators aim to additionally develop and internally validate a new risk prediction model. Methods: During the first phase of the study the investigators will perform external validation of existing prediction models. The performance, discrimination, calibration and clinical usefulness of the models will be evaluated. In the second phase of the study, in case performance of current risk assessment models is deemed insufficient for clinical application, the investigators will develop a model for predicting the risk of in-hospital VTE in critically ill patients. A multivariable prediction model will be constructed using a combination of predefined candidate predictors. This model will be internally validated and performance will be compared with performance of existing VTE risk prediction models. Dissemination: This protocol will be published online. This study will be reported according to the Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) statement and this study will be submitted to a peer-reviewed journal for publication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 9, 2022
CompletedFirst Posted
Study publicly available on registry
August 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedAugust 15, 2022
August 1, 2022
8.4 years
August 9, 2022
August 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with in-hospital VTE
VTE will be defined as any objectively proven event occurring during initial hospital admission. No screening protocol will be used. DVT will include acute thrombosis of lower-extremity veins (iliac, femoral or popliteal), confirmed by compression ultrasonography, venography, CT, MRI, or autopsy. Pulmonary embolism will be defined as acute thrombosis within the pulmonary vasculature as shown by ventilation-perfusion scan, CT angiography, or autopsy. We will include upper extremity DVT in the model but exclude venous thrombosis in any other site (e.g., portal vein thrombosis) as these may represent a different entity.
Initial hospital admission
Study Arms (4)
SICS I
Prospective cohort study based on the 'Simple Intensive Care Studies' (SICS) registry (NCT02912624)
SICS II
Prospective cohort study based on the 'Simple Intensive Care Studies' (SICS) registry (NCT03577405)
AFIB-ICU
An international inception cohort study.
Emmen
Patients admitted to the ICU of a community hospital in the Netherlands.
Eligibility Criteria
The target population are critically ill patients who are admitted to the ICU regardless of underlying disease. We will exclude patients who were admitted after planned surgery or other procedures. We foresee that there will be differences between the selection criteria of each cohort. We will reflect on these differences in the final manuscript
You may qualify if:
- Emergency admission
You may not qualify if:
- Age \< 18 years
- Planned admission either after surgery or for other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (12)
Wetterslev M, Moller MH, Granholm A, Haase N, Hassager C, Lange T, Hastbacka J, Wilkman E, Myatra SN, Shen J, An Y, Siegemund M, Young PJ, Aslam TN, Szczeklik W, Aneman A, Arabi YM, Cronhjort M, Keus F, Perner A. New-onset atrial fibrillation in the intensive care unit: Protocol for an international inception cohort study (AFIB-ICU). Acta Anaesthesiol Scand. 2021 Jul;65(6):846-851. doi: 10.1111/aas.13827. Epub 2021 Apr 23.
PMID: 33864378BACKGROUNDGaus H, Gulzow M, Meyer-Hofmann G. [Late lesions following thorotrast use]. Klin Wochenschr. 1966 Jan 1;44(1):32-9. doi: 10.1007/BF01747176. No abstract available. German.
PMID: 5984857BACKGROUNDSpyropoulos AC. Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost. 2009 Jun;7(6):1041-2. doi: 10.1111/j.1538-7836.2009.03351.x. No abstract available.
PMID: 19548912BACKGROUNDDarzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schunemann HJ. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
PMID: 33049056BACKGROUNDRiley RD, Debray TPA, Collins GS, Archer L, Ensor J, van Smeden M, Snell KIE. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med. 2021 Aug 30;40(19):4230-4251. doi: 10.1002/sim.9025. Epub 2021 May 24.
PMID: 34031906BACKGROUNDRiley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441. No abstract available.
PMID: 32188600BACKGROUNDVan Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016 Jun;74:167-76. doi: 10.1016/j.jclinepi.2015.12.005. Epub 2016 Jan 6.
PMID: 26772608BACKGROUNDVickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006 Nov-Dec;26(6):565-74. doi: 10.1177/0272989X06295361.
PMID: 17099194BACKGROUNDJanssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010 Jul;63(7):721-7. doi: 10.1016/j.jclinepi.2009.12.008. Epub 2010 Mar 24.
PMID: 20338724BACKGROUNDSullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30;23(10):1631-60. doi: 10.1002/sim.1742.
PMID: 15122742BACKGROUNDViarasilpa T, Panyavachiraporn N, Marashi SM, Van Harn M, Kowalski RG, Mayer SA. Prediction of Symptomatic Venous Thromboembolism in Critically Ill Patients: The ICU-Venous Thromboembolism Score. Crit Care Med. 2020 Jun;48(6):e470-e479. doi: 10.1097/CCM.0000000000004306.
PMID: 32187076BACKGROUNDSchunemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nunez JJ, Zhang Y, Wiercioch W. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
PMID: 30482763BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 9, 2022
First Posted
August 11, 2022
Study Start
March 1, 2015
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
August 15, 2022
Record last verified: 2022-08